ALT
Price
$2.92
Change
-$0.01 (-0.34%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
566.89M
44 days until earnings call
Intraday BUY SELL Signals
ARRY
Price
$7.91
Change
-$0.63 (-7.38%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.22B
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALT vs ARRY

ALT vs ARRY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALT vs. ARRY commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Hold and ARRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (ALT: $2.92 vs. ARRY: $8.54)
Brand notoriety: ALT and ARRY are both not notable
ALT represents the Biotechnology, while ARRY is part of the Alternative Power Generation industry
Current volume relative to the 65-day Moving Average: ALT: 131% vs. ARRY: 87%
Market capitalization -- ALT: $568.84M vs. ARRY: $1.22B
ALT [@Biotechnology] is valued at $568.84M. ARRY’s [@Alternative Power Generation] market capitalization is $1.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The market cap for tickers in the [@Alternative Power Generation] industry ranges from $118.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2B. The average market capitalization across the [@Alternative Power Generation] industry is $3.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileARRY’s FA Score has 1 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • ARRY’s FA Score: 1 green, 4 red.
According to our system of comparison, ARRY is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 6 TA indicator(s) are bullish while ARRY’s TA Score has 7 bullish TA indicator(s).

  • ALT’s TA Score: 6 bullish, 2 bearish.
  • ARRY’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, both ALT and ARRY are a good buy in the short-term.

Price Growth

ALT (@Biotechnology) experienced а +10.80% price change this week, while ARRY (@Alternative Power Generation) price change was +5.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

The average weekly price growth across all stocks in the @Alternative Power Generation industry was -3.18%. For the same industry, the average monthly price growth was -6.03%, and the average quarterly price growth was +3.21%.

Reported Earning Dates

ALT is expected to report earnings on Aug 06, 2026.

ARRY is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Alternative Power Generation (-3.18% weekly)

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($1.22B) has a higher market cap than ALT($567M). ARRY YTD gains are higher at: -7.375 vs. ALT (-18.975). ARRY has higher annual earnings (EBITDA): 29.6M vs. ALT (-88.27M). ALT has more cash in the bank: 332M vs. ARRY (201M). ALT has less debt than ARRY: ALT (35.8M) vs ARRY (763M). ARRY has higher revenues than ALT: ARRY (1.21B) vs ALT (36K).
ALTARRYALT / ARRY
Capitalization567M1.22B47%
EBITDA-88.27M29.6M-298%
Gain YTD-18.975-7.375257%
P/E RatioN/A56.91-
Revenue36K1.21B0%
Total Cash332M201M165%
Total Debt35.8M763M5%
FUNDAMENTALS RATINGS
ALT vs ARRY: Fundamental Ratings
ALT
ARRY
OUTLOOK RATING
1..100
2379
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
7953
P/E GROWTH RATING
1..100
10032
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALT's Valuation (94) in the Miscellaneous Commercial Services industry is in the same range as ARRY (98) in the Biotechnology industry. This means that ALT’s stock grew similarly to ARRY’s over the last 12 months.

ALT's Profit vs Risk Rating (100) in the Miscellaneous Commercial Services industry is in the same range as ARRY (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to ARRY’s over the last 12 months.

ALT's SMR Rating (99) in the Miscellaneous Commercial Services industry is in the same range as ARRY (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's Price Growth Rating (53) in the Biotechnology industry is in the same range as ALT (79) in the Miscellaneous Commercial Services industry. This means that ARRY’s stock grew similarly to ALT’s over the last 12 months.

ARRY's P/E Growth Rating (32) in the Biotechnology industry is significantly better than the same rating for ALT (100) in the Miscellaneous Commercial Services industry. This means that ARRY’s stock grew significantly faster than ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTARRY
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 13 days ago
88%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 15 days ago
84%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signal:
Gain/Loss:
ARRY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PARWX64.070.18
+0.28%
Parnassus Value Equity Investor
INDEX70.84N/A
N/A
CYBER HORNET S&P 500®
PRPAX6.56N/A
N/A
PGIM Jennison Energy Infrastructure A
NRINX30.47-0.09
-0.29%
Neuberger Intrinsic Value R6
GFFFX87.18-0.46
-0.52%
American Funds Growth Fund of Amer F2

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with ACHV. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then ACHV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
+8.33%
ACHV - ALT
45%
Loosely correlated
+5.05%
INDP - ALT
45%
Loosely correlated
-4.36%
AMRN - ALT
38%
Loosely correlated
-1.15%
LCTX - ALT
33%
Poorly correlated
+4.13%
ARRY - ALT
32%
Poorly correlated
+6.75%
More